Eli Lilly and Company’s Diabetes Setbacks May Spur Shopping Spree Beyond Amylin Pharmaceuticals, Inc.

Bloomberg -- Eli Lilly & Co., under pressure to gain new products after setbacks this week with two diabetes drugs, may try to acquire its partner Amylin Pharmaceuticals Inc. or covet companies with more approved products.